A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices.
about
Silver Nanoparticles: Technological Advances, Societal Impacts, and Metrological Challenges.Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteinsAlternative technique for calcium phosphate coating on titanium alloy implantsShort term serum pharmacokinetics of diammine silver fluoride after oral application.Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds.Chemical transformations of nanosilver in biological environmentsEffects of particle size and coating on toxicologic parameters, fecal elimination kinetics and tissue distribution of acutely ingested silver nanoparticles in a mouse model.An Evaluation of Blood Compatibility of Silver NanoparticlesSilver-Doped Calcium Phosphate Bone Cements with Antibacterial Properties.An effective treatment of experimental osteomyelitis using the antimicrobial titanium/silver-containing nHP66 (nano-hydroxyapatite/polyamide-66) nanoscaffold biomaterials.Decreased bacterial growth on titanium nanoscale topographies created by ion beam assisted evaporation.Calcium Phosphate Bioceramics: A Review of Their History, Structure, Properties, Coating Technologies and Biomedical Applications.Influence of the Microstructure and Silver Content on Degradation, Cytocompatibility, and Antibacterial Properties of Magnesium-Silver Alloys In Vitro.Clinical effectiveness, quality of life and cost-effectiveness of Flaminal® versus Flamazine® in the treatment of partial thickness burns: study protocol for a randomized controlled trial.Biocompatibility of silver containing silica films on Bioverit® II middle ear prostheses in rabbits.SilE is an intrinsically disordered periplasmic "molecular sponge" involved in bacterial silver resistance.Dermal argyria: Cutaneous manifestation of a megaprosthesis for distal femoral osteosarcoma.Investigation of DNA-damage and Chromosomal Aberrations in Blood Cells under the Influence of New Silver-based Antiviral Complex.In vitro and clinical experience of Cutimed Sorbact: the evidence base.Argyria -- case report.Synthesis, characterization, and antimicrobial activity of silver(I) and copper(II) complexes of phosphate derivatives of pyridine and benzimidazole.Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles.Comparative study of antibacterial effects and bacterial retentivity of wound dressings.Synthesis and potential applications of silver-porous aluminium oxide nanocomposites as prospective antiseptics and bactericides.Composition and properties of silver-containing calcium carbonate-calcium phosphate bone cement.Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen species-independent apoptosis.Ciprofloxacin-loaded calcium alginate wafers prepared by freeze-drying technique for potential healing of chronic diabetic foot ulcers.In vivo analysis of dermal and systemic absorption of silver nanoparticles through healthy human skin.Role of slough and biofilm in delaying healing in chronic wounds.Synergistic mechanism of Ag+-Zn2+ in anti-bacterial activity against Enterococcus faecalis and its application against dentin infection.A Novel Antimicrobial Coating Represses Biofilm and Virulence-Related Genes in Methicillin-Resistant Staphylococcus aureus.Orthopaedic device-related infection: current and future interventions for improved prevention and treatment.The Management of Critically Colonized and Locally Infected Leg Ulcers with an Acid-Oxidizing Solution: A Pilot Study.Silver-Functionalized Bacterial Cellulose as Antibacterial Membrane for Wound-Healing Applications.In VivoEvaluation of Complex Biogenic Silver Nanoparticle and Enoxaparin in Wound HealingSilver and Antibiotic, New Facts to an Old StoryState-of-the-Art, and Perspectives of, Silver/Plasma Polymer Antibacterial Nanocomposites
P2860
Q29248033-C54004E5-D0A4-44B7-8C57-AAB16F141B25Q30407161-44F7A692-54A6-4962-A10A-35AFD1DB0538Q33568174-0A725127-7AE4-4840-8DE6-A56A100DE765Q34526443-619D61B2-5974-40BE-996A-47A81339D7EFQ35425209-B4BF4A28-3874-430A-A9D5-A85CB54921D3Q36429033-83410784-1100-4776-ACE9-0EB826C835BFQ36619973-8F48AB79-0A76-45B0-AAFC-886DC71C0495Q36870738-1074F468-C4A0-4D0F-9766-D8A0B8E084BCQ37063871-7DF7745F-9168-4B3F-9716-C3CA66769648Q37508575-6B4AC1C2-0F5D-48E8-8A54-6C6DF8303B6CQ37643469-4342E415-209D-4F76-AFEA-F3DF55D39778Q38647414-2E904BB8-FDFA-4F09-B724-DFC528ECC6AAQ38674683-89A441C5-5771-4526-8A0E-17B41560888BQ38792493-86A52678-5198-4E29-8535-20E2F80755EEQ39042273-57EBFF57-30B4-49C9-9F44-6DAB7BBB6084Q39846204-24764F8D-312F-4138-9987-31E11E5ABB56Q40530492-D40E6A8D-920A-4C7E-A84C-82136F374E9AQ40695777-85A48295-DAA8-4D48-B94C-04DD02F27010Q41158472-5DFD3F5E-79AC-40FA-A520-FA7EDB302483Q42015336-3B17C117-D7D2-4F39-A0F4-CE3542E78B72Q42708473-8102B955-A7FA-498E-9AA7-8D664ECB8F2CQ42732635-21D4E1F4-11A0-4DE3-BE1F-008499ED95FCQ43024410-17D6AF53-D7DA-4E16-9FBE-26E3A31B25F8Q43359338-3C3A7E93-350E-42AA-B424-8E78C09FC5D5Q45339565-3329C319-0375-4D12-9220-C25A1FC21460Q46252995-2464B2B8-E337-48AA-AD38-56D157CBA415Q47351561-60F1EB4F-E06D-4889-8525-2DBA33157811Q47723476-433E7D61-12DF-4B13-B312-E0D90232D166Q48599102-3BFBAEE6-03CA-4CEB-87CF-993249ED6D5FQ49174844-CBE783DE-B0BA-42C0-BD98-291844E47BB7Q50351209-9C271303-9E41-4B9F-BC76-9FF4A65263C4Q50893725-ECF1AF38-806E-46E2-B0D5-55484389192CQ52645290-C3CFFA7D-E5A6-4819-BA40-A380C4F9D3A1Q55709003-D5A6C212-DFCC-473A-B872-AB5FF066B40DQ58161554-B75B8284-A814-49CA-87E1-2D66F0843A31Q58717448-0F50098B-6FBD-40BF-BFEE-739F3EE75910Q58767504-75C20873-B86A-4604-B2D0-482A45C6AFB8
P2860
A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A pharmacological and toxicolo ...... bial agent in medical devices.
@ast
A pharmacological and toxicolo ...... bial agent in medical devices.
@en
A pharmacological and toxicolo ...... bial agent in medical devices.
@nl
type
label
A pharmacological and toxicolo ...... bial agent in medical devices.
@ast
A pharmacological and toxicolo ...... bial agent in medical devices.
@en
A pharmacological and toxicolo ...... bial agent in medical devices.
@nl
prefLabel
A pharmacological and toxicolo ...... bial agent in medical devices.
@ast
A pharmacological and toxicolo ...... bial agent in medical devices.
@en
A pharmacological and toxicolo ...... bial agent in medical devices.
@nl
P2860
P356
P1476
A pharmacological and toxicolo ...... bial agent in medical devices.
@en
P2093
Alan B G Lansdown
P2860
P304
P356
10.1155/2010/910686
P577
2010-08-24T00:00:00Z